These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24023308)

  • 1. Frequent promoter methylation of CDH1 in non-neoplastic mucosa of sporadic diffuse gastric cancer.
    Lee KH; Hwang D; Kang KY; Lee S; Kim DY; Joo YE; Lee JH
    Anticancer Res; 2013 Sep; 33(9):3765-74. PubMed ID: 24023308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
    Machado JC; Oliveira C; Carvalho R; Soares P; Berx G; Caldas C; Seruca R; Carneiro F; Sobrinho-Simöes M
    Oncogene; 2001 Mar; 20(12):1525-8. PubMed ID: 11313896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
    BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
    J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unsolved enigma of CDH1 down-regulation in hereditary diffuse gastric cancer.
    Concolino P; Papa V; Mozzetti S; Ferlini C; Pacelli F; Martinelli E; Ricci R; Filippetti F; Scambia G; Doglietto GB
    J Surg Res; 2004 Sep; 121(1):50-5. PubMed ID: 15313375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil.
    Borges Bdo N; Santos Eda S; Bastos CE; Pinto LC; Anselmo NP; Quaresma JA; Calcagno DQ; Burbano RM; Harada ML
    Anticancer Res; 2010 Jun; 30(6):2225-33. PubMed ID: 20651373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of DNA methylation in the development of diffuse-type gastric cancer.
    Yamamoto E; Suzuki H; Takamaru H; Yamamoto H; Toyota M; Shinomura Y
    Digestion; 2011; 83(4):241-9. PubMed ID: 21273772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
    Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
    J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
    Zhou YN; Xu CP; Han B; Ji R
    Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.
    Grady WM; Willis J; Guilford PJ; Dunbier AK; Toro TT; Lynch H; Wiesner G; Ferguson K; Eng C; Park JG; Kim SJ; Markowitz S
    Nat Genet; 2000 Sep; 26(1):16-7. PubMed ID: 10973239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
    Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
    Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
    Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Digestion; 2010; 82(1):27-36. PubMed ID: 20150736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Promoter methylation profile in gastric cancer].
    Roa JC; Anabalón L; Roa I; Tapia O; Melo A; Villaseca M; Araya JC
    Rev Med Chil; 2005 Aug; 133(8):874-80. PubMed ID: 16163424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [E-cadherin expression and CDH1 promoter methylation in sporadic and hereditary gastric cancer].
    Li XJ; Zhao Y; Ren H
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):125-7. PubMed ID: 25613626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
    Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
    Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [E-cadherin expression and CDH1 promoter methylation in sporadic and hereditary gastric cancer].
    Li XJ; Zhao Y; Ren H
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):125-7. PubMed ID: 23353171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients.
    Muretto P; Ruzzo A; Pizzagalli F; Graziano F; Maltese P; Zingaretti C; Berselli E; Donnarumma N; Magnani M
    Ann Oncol; 2008 Mar; 19(3):516-9. PubMed ID: 17986624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.